SPINT1 and carcinoma: Moreover, dysregulation of matriptase's cognate inhibitors, such as hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2), has been observed in carcinomas [9,[11], [12], [13], [14]].